Skip to main content

Table 2 Patient characteristics: lung diseases

From: Use of a sealant to prevent prolonged air leaks after lung resection: a prospective randomized study

Diagnosis Control group n (%) Sealant group n (%)
Total n, (%) 105 (100.0) 111 (100.0)
Malignant disease 75 (71.5) 82 (73.9)
Primary lung neoplasm 52 (49.5) 47 (42.3)
 Adenocarcinoma 33 (31.4) 18 (16.2)
 Epidermoid 18 (17.1) 16 (14.4)
 Bronchoalveolar 10 (9.52) 5 (4.50)
 Poorly differentiated 5 (4.76) 3 (2.70)
 Adenosquamous 3 (2.86) 1 (0.90)
 Neuroendocrine 3 (2.86) 1 (0.90)
 Typical carcinoid 3 (2.86) 2 (1.80)
 Atypical carcinoid 0 (0.0) 1 (0.90)
Metastasis 23 (21.9) 35 (31.5)
 Kidney 2 (1.90) 4 (3.60)
 Ovarian 1 (0.95) 7 (6.31)
 Skin 1 (0.95) 3 (2.70)
 Salivary ducts 2 (1.90) 1 (0.90)
 Prostatic 2 (1.90) 3 (2.70)
 Breast 14 (13.3) 11 (9.91)
 Colorectal 2 (1.90) 6 (5.40)
Benign disease 30 (28.6) 29 (26.1)
Flogistic 23 (21.9) 23 (20.7)
Disonthogenetic 5 (4.76) 5 (4.50)
Hydatid cyst 2 (1.90) 1 (0.90)